Apatinib combined with PD-L1 blockade synergistically enhances antitumor immune responses and promotes HEV formation in gastric cancer

Zhang, Y; Wang, F; Sun, HR; Huang, YK; Gao, JP; Huang, H

Huang, H (corresponding author), Fudan Univ, Dept Gastr Surg, Shanghai Canc Ctr, Shanghai, Peoples R China.; Huang, H (corresponding author), Fudan Univ, Shanghai Med Coll, Dept Oncol, 270 Dongan Rd, Shanghai 200032, Peoples R China.

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2021; 147 (8): 2209

Abstract

Purpose Apatinib, an antiangiogenic drug, has shown beneficial effects only in a fraction of advanced gastric cancer (GC) patients. Given the recent s......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索